ロード中...
Remdesivir in a pregnant patient with COVID-19 pneumonia
Remdesivir is an antiviral drug currently being studied as a potential treatment of pneumonia caused by infection with SARS-CoV-2. The Adaptive Covid-19 Treatment Trial (ACTT-1) by NIH and the SIMPLE study by Gilead Sciences are two major trials that showed promising results of Remdesivir in the non...
保存先:
| 出版年: | J Community Hosp Intern Med Perspect |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7850401/ https://ncbi.nlm.nih.gov/pubmed/33552429 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20009666.2020.1857510 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|